References
[1] Mozaheb Z, Khooei A. Bilateral Conjunctival Infiltration as an Extramedullary Relapse of AML [J]. Case Reports in Hematology. 2018: 1-3.
[2] Yuda S, Fuji S, Onishi A, et al. Extramedullary Relapse of Acute Myelogenous Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation [J]. Biology of Blood and Marrow Transplantation. 2019, 25(6): 1152-1157.
[3] Leukemia and Lymphoma Group, Hematology Branch of Chinese Medical Association. Chinese guidelines for the diagnosis and treatment of relapsed and refractory acute myeloid leukemia (2017 edition) [J]. The Chinese Journal of Hematology. 2017, 38(3):183-184.
[4] Yoshihara S, Ikegame K, Kaida K, et al. Incidence of extramedullary relapse after haploidentical SCT for advanced AML/myelodysplastic syndrome [J]. Bone Marrow Transplantation. 2012, 47(5): 669-676.
[5] Clark W B, Strickland S A, Barrett A J, et al. Extramedullary relapses after allogeneic stem cell transplantation for acute myeloid leukemia and myelodysplastic syndrome [J]. Haematologica. 2010, 95(6): 860-863.
[6] Young Kim J, Ah Im S, Hyun Lee J, et al. Extramedullary Relapse of Acute Myeloidand Lymphoid Leukemia in Children: A Retrospective Analysis [J]. Iranian Journal of Pediatrics. 2016, In Press(In Press).
[7] Kiratli H, Demiroğlu H, Emeç S. Ocular relapse in acute myeloid leukemia (M4) with normal bone marrow [J]. International Ophthalmology. 2009, 29(4): 243-245.
[8] Facenda-Lorenzo M, Sánchez-Quintana A, Quijada-Fumero A, et al. Cardiac Relapse of Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation [J]. Case Reports in Oncological Medicine. 2016: 1-5.
[9] Kim S J, Kim W G. Sonographic Features of a Myeloid Sarcoma of the Breast as a Relapse of Acute Myeloid Leukemia After Stem-Cell Transplantation: A Case Report [J]. American Journal of Case Reports. 2019, 20: 612-619.
[10] Mazzaglia P J, Strenger R, Castillo J J. Extramedullary relapse of acute myeloid leukemia in a surgical wound [J]. Leukemia & Lymphoma. 2011, 52(3): 541-543.
[11] Imanaka R, Katayama Y, Iwato K, et al. Acute leukemia recurring as extramedullary tumors of the ovary following allogeneic hematopoietic stem cell transplantation [J]. [Rinsho ketsueki] The Japanese journal of clinical hematology. 2018, 59(1): 58.
[12] Kahn R M, Gordhandas S, Chapman-Davis E, et al. Acute Myeloid Leukemia Presenting as Myeloid Sarcoma with a Predisposition to the Gynecologic Tract [J]. Case Reports in Oncological Medicine. 2019: 1-5.
[13] Goh B S, Tang C L, Tan G C. Myeloid Sarcoma of Temporal Bone: A Rare Manifestation of Relapse Acute Myeloid Leukemia[J]. Indian Journal of Otolaryngology and Head & Neck Surgery. 2019, 71(S2): 1023- 1026.
[14] Alhashim N, Aljurf M, Hassanein M, et al. Extramedullary relapses after allogeneic stem cell transplantation for acute myeloid leukemia: clinical characteristics, incidence, risk factors and outcomes [J]. Bone Marrow Transplantation. 2018, 53(7): 838-843.
[15] Stölzel F, Röllig C, Radke J, et al. 18F-FDG-PET/CT for detection of extramedullary acute myeloid leukemia [J]. Haematologica. 2011, 96(10): 1552- 1556.
[16] Rao S, Langston A, Galt J R, et al. Extramedullary Acute Myeloid Leukemia and the Use of FDG-PET/CT [J]. Clinical Nuclear Medicine. 2009, 34(6): 365-366.
[17] de Bonilla Damiá Á, Fernández López R, Acevedo Báñez I, et al. PET/TC con 18F-FDG en la recaída extramedular de una leucemia aguda de linaje ambiguo [J]. Revista Española de Medicina Nuclear e Imagen Molecular. 2019, 38(6): 395-396.
[18] Inoue K, Ogawa H, Yamagami T, et al. Long-term follow-up of minimal residual disease in leukemia patients by monitoring WT1 (Wilms tumor gene) expression levels [J]. Blood. 1996, 88(6): 2267-2278.
[19] Krauter J, Wattjes M P, Nagel S, et al. Real-time RT-PCR for the detection and quantification of AML1/MTG8 fusion transcripts in t(8;21)-positive AML patients [J]. British Journal of Haematology. 1999, 107(1): 80-85.
[20] Ishikawa Y, Kawashima N, Atsuta Y, et al. Prospective evaluation of prognostic impact of KIT mutations on acute myeloid leukemia with RUNX1-RUNX1T1 and CBFB-MYH11[J]. Blood Advances. 2020, 4(1): 66-75.
[21] Lee J W, Kim S, Jang P, et al. Prognostic Role of Postinduction Minimal Residual Disease and Myeloid Sarcoma Type Extrame-dullary Involvement in Pediatric RUNX1-RUNX1T1 (+) Acute Myeloid Leukemia [J]. Journal of Pediatric Hematolo-gy/Oncology. 2020: 1.
[22] Fan Ying. Changes in biological markers after relapse in acute myeloid leukemia [D]. Hebei Medical University. 2012.
[23] Ge L, Ye F, Mao X, et al. Extramedullary Relapse of Acute Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation: Different Characteristics between Acute Myelogenous Leukemia and Acute Lymphoblastic Leukemia [J]. Biology of Blood and Marrow Transplantation. 2014, 20(7): 1040- 1047.
[24] Harris A C, Kitko C L, Couriel D R, et al. Extramedullary relapse of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcomes [J]. Haematologica. 2013, 98(2): 179- 184.
[25] Chan J K, Tsang W Y, Lau W H, et al. Aggressive T/natural killer cell lymphoma presenting as testicular tumor [J]. Cancer. 1996, 77(6): 1198.
[26] Jiang L, Meng W, Yu G, et al. MicroRNA‑ 144 targets APP to regulate AML1/ETO+ leukemia cell migration via the p‑ERK/c‑Myc/MMP‑2 pathway [J]. Oncology Letters. 2019.
[27] Lee J H, Choi S J, Seol M, et al. Anti-leukemic effect of graft-versus-host disease on bone marrow and extramedullary relapses in acute leukemia [J]. Haematologica. 2005, 90(10):1380.
[28] Schäfer H, Bader P, Kaiserling E, et al. Extramedullary relapses at uncommon sites after allogeneic stem cell transplantation [J]. Bone marrow transplantation. 2000, 26(10):1133- 1134.
[29] Mo X, Kong J, Zhao T, et al. Extramedullary Relapse of Acute Leukemia after Haploidentical Hematopoietic Stem Cell Transplan-tation: Incidence, Risk Factors, Treatment, and Clinical Outcomes [J]. Biology of Blood and Marrow Transplantation. 2014, 20(12): 2023-2028.
[30] Hadid. Leptomeningeal Relapse of Acute Promyelocytic Leukemia [J]. World Journal of Oncology. 2014, 5(2): 77-80.
[31] Gunes G, Goker H, Demiroglu H, et al. Extramedullary relapses of acute leukemias after allogeneic hematopoietic stem cell trans-plantation: clinical features, cumulative incidence, and risk factors [J]. Bone Marrow Transplantation. 2019, 54(4): 595-600.
[32] Sun Yuqian, Huang Xiaojun. Improved strategy for efficacy after allogeneic hematopoietic stem cell transplantation in relapsed leukemia [J]. The Chinese Journal of Hematology. 2017, 38(8):732-736.
[33] Jin M, Hu Y, Wu W, et al. Decitabine plus CLAG chemotherapy as a bridge to haploidentical transplantation in the setting of acute myeloid leukemia relapse after HLA-matched sibling transplantation: a case report [J]. BMC Cancer. 2019, 19(1): 242.
[34] Zhou T, Bloomquist M S, Ferguson L S, et al. Pediatric myeloid sarcoma: a single institution clinicopathologic and molecular analysis [J]. Pediatric Hematology and Oncology. 2020, 37(1): 76-89.
[35] Imanaka R, Katayama Y, Iwato K, et al. Acute leukemia recurring as extramedullary tumors of the ovary following allogeneic hematopoietic stem cell transplantation [J]. [Rinsho ketsueki] The Japanese journal of clinical hematology. 2018, 59(1): 58.
[36] Ochi T, Iwato K, Katayama Y, et al. Post-allogeneic stem cell transplant extramedullary relapse of acute megakaryoblastic leukemia initially detected by elevated WT1 mRNA levels in peripheral blood [J]. Rinsho Ketsueki. 2016, 57(11): 2319-2323.
[37] Schuler E, Boughoufala S, Rautenberg C, et al. Relapse patterns and treatment strategies in patients receiving allogeneic hematopoietic stem cell transplantation for myeloid malignancies [J]. Annals of Hematology. 2019, 98(5): 1225-1235.